These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9831913

  • 21. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M, Kruhoeffer M, Gregersen S, Agger A, Jeppesen P, Oerntoft T, Hermansen K.
    Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
    [Abstract] [Full Text] [Related]

  • 22. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function.
    Király MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, Riddell MC, Vranic M.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E271-83. PubMed ID: 18029442
    [Abstract] [Full Text] [Related]

  • 23. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ.
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [Abstract] [Full Text] [Related]

  • 24. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK, Rosenthal MJ, Song AM, Yang H, Ao Y, Yamaguchi DT.
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [Abstract] [Full Text] [Related]

  • 25. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats.
    Atkinson LL, McDonald-Dyck C, Benkoczi C, Finegood DT.
    Diabetes Obes Metab; 2008 Sep; 10(9):780-90. PubMed ID: 17970758
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C, Forcheron F, Abdallah P, Basset A, Del Carmine P, Bricca G, Beylot M.
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
    Fiedler M, Zierath JR, Selén G, Wallberg-Henriksson H, Liang Y, Sakariassen KS.
    Diabetologia; 2001 Dec; 44(12):2180-6. PubMed ID: 11793019
    [Abstract] [Full Text] [Related]

  • 30. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK, Zhao ZS, Lee YJ, Lee KE, Kang SM, Choi D, Lim SK, Chung N, Lee HC, Cha BS.
    Diabetes Metab Res Rev; 2003 Dec; 19(6):487-93. PubMed ID: 14648808
    [Abstract] [Full Text] [Related]

  • 31. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
    Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Van Arsdall M, Adrogue JV, Brown KK, Taegtmeyer H.
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E328-36. PubMed ID: 15797988
    [Abstract] [Full Text] [Related]

  • 32. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y, Donahue EP, Shiota M.
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW.
    Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
    Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, Arch JR, Wilson S, Williams G.
    Brain Res Mol Brain Res; 2000 Apr 14; 77(1):131-7. PubMed ID: 10814839
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.